Barinthus Biotherapeutics plc / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) N/A -€57.21M +2.8% N/A N/A N/A
    (estimated) €0.00 +NaN% -€55.64M -10.8% N/A N/A N/A
    (estimated) €0.00 -100.0% -€62.38M +18.5% N/A N/A N/A
    €12.90M +1,766.5% -€52.62M -16.7% -408.0% +87 pp -€24.16M -38.4% -187.4% +55 pp
    €690.96K -98.2% -€63.19M -1,473.0% -9,145.5% -92 pp -€39.21M +448.8% -5,674.8% -57 pp
    €38.51M +16,580.2% €4.60M -110.5% 11.9% +190 pp -€7.14M -73.6% -18.6% +120 pp
    €230.90K -94.4% -€43.82M +187.3% -18,979.5% -190 pp -€27.08M +192.8% -11,730.2% -120 pp
    €4.15M -29.9% -€15.25M -14.9% -367.3% -0.64 pp -€9.25M -42.4% -222.7% +0.48 pp
    €5.92M -€17.93M -302.9% -€16.05M -271.1%

    Notifications